Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Medical Countermeasures

    Ragon Institute Brings New Perspectives to Vaccine Development

    By Global Biodefense StaffMarch 4, 2013
    Share
    Facebook LinkedIn Reddit Email

    Scanning electron microscope image of a lymphocyte with HIV clusterEngineers and physical scientists at the Ragon Institute are joining immunologists and physicians in the battle against infectious disease by contributing new approaches to medical countermeasures technology, materials and computational studies.

    The primary mission of the Ragon Institute — launched jointly in 2009 by Massachusetts General Hospital (MGH), MIT and Harvard University — is to develop new HIV vaccines through better understanding of how the immune system responds to infection. Bruce Walker, the MGH physician who directs the institute, says it was important to enlist engineers and physical scientists, who have usually been excluded from traditional HIV research, to contribute different tools and approaches to the problem.

    The organization encourages its researchers to develop new technology and pursue ideas that might not be funded through traditional channels. These include new materials for vaccine delivery and new technology for studying the virus’s interactions with the immune system.

    For example, Darrell Irvine, an MIT professor of materials science and engineering and member of the Koch Institute, is working on a new polymer film that can deliver DNA vaccines under the skin. DNA vaccines were first tested about 20 years ago and found to elicit strong immune responses in rodents but have thus far failed to provoke any protective immunity in human clinical trials. 

    With the new polymer film developed by Irvine and his colleagues, DNA vaccines are embedded in layers of polymer films that gradually degrade, releasing the vaccine over days or weeks. The film also includes an adjuvant consisting of a strand of RNA similar to viral RNA. This molecule provokes inflammation in the target tissue, which helps to recruit immune cells to the area, so they can encounter the antigen encoded by the DNA.

    The vaccine-delivering film showed success in tests of mice, and the researchers now hope to test it in nonhuman primates. Much of this work would likely not have happened without both funding from the Ragon Institute and the interdisciplinary collaborations that have arisen because of the institute.

    “It’s been absolutely fantastic for me and many of the MIT faculty that have been involved,” Irvine says. “There are really two paths being followed at all times: a very focused mission to try and get an HIV vaccine developed, but also an interest in making sure that we don’t miss new opportunities in the basic science that might bring totally new vaccine concepts forward.”

    Read the rest of the story by Anne Trafton at MIT News. 

    Source: MIT News. Image credit: National Cancer Institute.

    Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleIntegenX Teams with SAIC to Pursue Biodetection Contracts
    Next Article Report: Child ‘Functionally Cured’ of HIV Infection

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy